As of 2025-10-31, the Fair Value of Verrica Pharmaceuticals Inc (VRCA) is -25.71 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.53 USD, the upside of Verrica Pharmaceuticals Inc is -828.45%.
With the market price of 3.53 USD and our fair value calculation, Verrica Pharmaceuticals Inc (VRCA) is not a good investment. Investing in VRCA stocks now will result in a potential loss of 828.45%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -42.69 | -35.08 | -24.49 | -67.00 | -76.58 | -49.17 |
| YoY growth | -51.33% | 17.83% | 30.19% | -173.56% | -14.31% | -38.24% |
| Market Cap (mil) | 33.36 |
| P/E | |
| Forward P/E |
| EPS | -5.14 |
| Avg earnings growth rate | -38.24% |
| TTM earnings | -48.60 |